230.77

2.09% 4.73

After Hours: 230.77

West Pharmaceutical Services Inc (WST)

Overview News Price History Option Chain Financials Why WST Down? Discussions Forecast Stock Split Dividend History

West Pharmaceutical Services Inc stock is traded at $230.77, with a volume of 1.22M. It is up +2.09% in the last 24 hours and down -28.42% over the past month. West Pharmaceutical Services is based in Pennsylvania, US, and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), non-glass containment solutions, and auto-injectors for injectable drugs, which include large molecule biologics, peptides such as GLP-1 receptor agonists, and small molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

Previous Close:

$226.04

Open:

$227.93

24h Volume:

1.22M

Relative Volume:

1.54

Market Cap:

$16.69B

Revenue:

$2.88B

Net Income/Loss:

$499.60M

P/E Ratio:

34.24

EPS:

6.74

Net Cash Flow:

$321.60M

1W Performance:

+2.31%

1M Performance:

-28.42%

6M Performance:

-23.67%

1Y Performance:

-35.45%

1-Day Range:

$226.90

$234.36

1-Week Range:

$222.26

$236.71

52-Week Range:

$197.01

$400.88

West Pharmaceutical Services Inc Stock (WST) Company Profile

Name

West Pharmaceutical Services Inc

Sector

Healthcare (1170)

Industry

Medical Instruments & Supplies (62)

Phone

(610) 594-2900

Address

530 HERMAN O. WEST DRIVE, EXTON, PA

Employee

10,600

Twitter

@WestPharma

Next Earnings Date

2024-10-24

Latest SEC Filings

WST's Discussions on Twitter

Compare WST with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
WST West Pharmaceutical Services Inc	230.77	16.69B	2.88B	499.60M	321.60M	6.74
ISRG Intuitive Surgical Inc	493.72	176.09B	8.35B	2.32B	1.30B	6.41
BDX Becton Dickinson Co	224.92	64.58B	20.64B	1.73B	2.94B	6.02
ALC Alcon Inc	89.15	44.10B	9.91B	1.02B	665.00M	2.05
RMD Resmed Inc	225.79	33.17B	4.93B	1.25B	1.38B	8.47
BAX Baxter International Inc	35.85	18.30B	17.28B	108.00M	391.00M	0.20

West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-14-25	Upgrade	Deutsche Bank	Hold → Buy
Jan-08-25	Initiated	Citigroup	Buy
Dec-13-24	Initiated	Wolfe Research	Peer Perform
Dec-12-24	Upgrade	UBS	Neutral → Buy
Feb-07-24	Upgrade	Jefferies	Hold → Buy
Jun-16-23	Upgrade	BofA Securities	Neutral → Buy
Apr-11-23	Upgrade	Stephens	Equal-Weight → Overweight
Dec-14-22	Initiated	Deutsche Bank	Hold
Nov-30-22	Initiated	UBS	Neutral
Oct-28-22	Downgrade	BofA Securities	Buy → Neutral
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight
Oct-14-20	Initiated	Stephens	Equal-Weight
Jul-21-20	Upgrade	BofA Securities	Neutral → Buy
Apr-24-20	Upgrade	BofA/Merrill	Underperform → Neutral
Dec-12-19	Downgrade	BofA/Merrill	Neutral → Underperform
Jul-26-19	Upgrade	BofA/Merrill	Underperform → Neutral
May-01-19	Downgrade	Jefferies	Buy → Hold
Apr-23-19	Initiated	William Blair	Outperform
Apr-25-18	Downgrade	BofA/Merrill	Neutral → Underperform
Jan-24-18	Initiated	Goldman	Neutral
Oct-17-17	Downgrade	BofA/Merrill	Buy → Neutral
Oct-03-17	Initiated	Stephens	Equal-Weight
Sep-15-17	Upgrade	Jefferies	Hold → Buy
Oct-28-16	Upgrade	Wells Fargo	Market Perform → Outperform
Sep-21-16	Downgrade	Wells Fargo	Outperform → Market Perform
Mar-22-16	Initiated	Wells Fargo	Outperform
May-14-10	Reiterated	UBS	Neutral
Feb-23-10	Initiated	Jefferies & Co	Buy
Dec-19-08	Initiated	UBS	Neutral

View All

West Pharmaceutical Services Inc Stock (WST) Latest News

04:33 AM

West Pharmaceutical Announces Leadership Transition - TipRanks

04:33 AM

11:28 AM

Meeting Annex 1 Regulations: A Proactive Approach To Regulatory Compliance - Med Device Online

11:28 AM

07:53 AM

Lost Money on West Pharmaceutical Services, Inc. (WST)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire

07:53 AM

02:15 AM

West Pharmaceutical: Remains A Strong Long-Term Prospect (NYSE:WST) - Seeking Alpha

02:15 AM

Mar 10, 2025

West Pharmaceutical Services to Present at Major 2025 Healthcare Conferences - MSN

Mar 10, 2025

Zacks Research Has Bearish Estimate for WST Q1 Earnings - Defense World

Mar 10, 2025

Mar 09, 2025

Why West Pharmaceutical Services, Inc. (WST) Is Plunging So Far In 2025 - Insider Monkey

Mar 09, 2025

A Look At The Intrinsic Value Of West Pharmaceutical Services, Inc. (NYSE:WST) - Yahoo Finance

Mar 09, 2025

FY2027 Earnings Forecast for WST Issued By Zacks Research - Defense World

Mar 09, 2025

Mar 05, 2025

West Pharmaceutical Services (NYSE:WST) Has A Pretty Healthy Balance Sheet - Simply Wall St

Mar 05, 2025

West to Participate in Upcoming Investor Conferences -March 05, 2025 at 06:01 am EST - Marketscreener.com

Mar 05, 2025

West Pharmaceutical Sets Key Investor Conference ScheduleHow to Access Their March Presentations - StockTitan

Mar 05, 2025

Most Frequently Asked Questions On The Revised EU GMP Annex 1: Volume 2 - Med Device Online

Mar 05, 2025

Mar 04, 2025

Lost Money on West Pharmaceutical Services, Inc.(WST)? You May Have Been Affected by FraudContact Levi & Korsinsky - ACCESS Newswire

Mar 04, 2025

Private Advisor Group LLC Trims Position in West Pharmaceutical Services, Inc. (NYSE:WST) - Defense World

Mar 04, 2025

Mar 01, 2025

West Pharmaceutical Services, Inc. (NYSE:WST) Receives $344.00 Consensus Target Price from Brokerages - Defense World

Mar 01, 2025

Feb 28, 2025

West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MSN

Feb 28, 2025

West Pharmaceutical's Long-Term Growth Intact, but Margin Expansion Less Uncertain - Morningstar

Feb 28, 2025

Do Wall Street Analysts Like West Pharmaceutical Services Stock? - MSN

Feb 28, 2025